<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03618329</url>
  </required_header>
  <id_info>
    <org_study_id>PRERAS</org_study_id>
    <nct_id>NCT03618329</nct_id>
  </id_info>
  <brief_title>Effect of Prehabilitation on the Lean Mass Index (IMM) in ERAS PROGRAMM.</brief_title>
  <acronym>PRERAS</acronym>
  <official_title>Effect of Prehabilitation on the Lean Mass Index (IMM) in Patients Operated on for Colon Cancer in ERAS Programm.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The implementation of prehabilitation in patients operated on for colon cancer in a
      multimodal rehabilitation regimen improves the values of the &quot;lean body mass&quot; or lean mass
      index, positively influencing the results of clinical, analytical and radiological
      nutritional values pre- and postoperatively and in morbi-mortality, recovery, average stay
      and re-entry rates.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of prehabilitation on the change from lean mass index</measure>
    <time_frame>preoperative and 1-month postoperative</time_frame>
    <description>Effect of prehabilitation on the lean mass index</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Colo-rectal Cancer</condition>
  <condition>Nutrition Disorders</condition>
  <arm_group>
    <arm_group_label>Prehabilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>exercise, nutrition and anxiety reduction in the preoperative period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Prehabilitation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Not: exercise, nutrition and anxiety reduction in the preoperative period</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prehabilitation</intervention_name>
    <description>exercise, nutrition and anxiety reduction in the preoperative period</description>
    <arm_group_label>Prehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  It is considered that the subject suffers a confirmed diagnosis of colon cancer and is
             going to undergo surgery on a scheduled basis under a RHMM program.

          -  The subject is ≥ 18 years of age.

          -  The subject can perform any of the two proposed treatments.

          -  Preoperative staging TxNxM0.

          -  The patient has voluntarily signed and dated an informed consent document (IC),
             approved by an independent Ethics Committee (CEIC) before participating in the study.

        Exclusion Criteria:

          -  Patients with rectal cancer.

          -  The study doctor determines that the subject is not eligible to participate.

          -  The subject can not give informed consent to participate in the study.

          -  The subject can not perform the pre-habilitation.

          -  Non-acceptance or impossibility of following rehabilitation protocol multimodal

          -  The subject was previously scheduled at the time of the inclusion of the nutritional
             supplement study, whether it is different or the same that would be scheduled at this
             time

          -  Subjects who have received previous radiochemotherapy, HIV, gestational stage,
             psychiatric, with CRF who are undergoing renal replacement techniques, urgent surgery,
             with intestinal obstructions, with uncontrolled infections, urgent surgery, distant
             metastasis, ASA IV, advanced liver failure, severe coagulation disorder, severe
             hyperlipidemia and hyperglycemia or difficult to control.

          -  Subject has renal or hepatic impairment (GFR &lt;60ml / m or AST / ALT 3 x upper limit of
             normal).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>July 31, 2018</study_first_submitted>
  <study_first_submitted_qc>August 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2018</study_first_posted>
  <last_update_submitted>August 4, 2018</last_update_submitted>
  <last_update_submitted_qc>August 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana</investigator_affiliation>
    <investigator_full_name>Antonio Arroyo Sebastian</investigator_full_name>
    <investigator_title>Prof</investigator_title>
  </responsible_party>
  <keyword>COLON CANCER</keyword>
  <keyword>ERAS</keyword>
  <keyword>NUTRITION</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nutrition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

